In this study we want to learn about how safe and how well a new skin cream works to treat children with a skin condition called hidradenitis suppurativa.
Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 Years of Age With Severe Alopecia Areata
In this study we want to learn how well a cream called Ruxolitinib works to treat vitiligo on the face and body of children between 2 and 12 years old.